pancreatic cancer
Conditions
Interventions
To investigate the frequency of histological curative resection following chemoradiation using S1 combined with RT for resectable and borderline resectable (BR-PV) pancreatic ductal adenocarcinoma
Sponsors
Department of Gastroenterological Surgery, Faculty of Medicine, Kagawa University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients with radiologically defined patentially resectable pancreatic cancer 2) Patients who have not undergone radiotherapy to the abdomen 3) Patients who have not undergone chemotherapy within 6 months 4) Patients with Performance status of 0/1 5) Patients with sustained organ function 6) Patients who received informed consent
Exclusion criteria
Exclusion criteria: 1) Patients with other active cancers 2) Patients who can not take medicine orally 3) Patients with severe allergies 4) Patients with watery diarrhea 5) Patients with severe co-morbid disease 6) Patients seems inadequate for this study by investigator(s)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Histological curative resection (R0 ratio) | — |
Secondary
| Measure | Time frame |
|---|---|
| Pathological responce rate, Incident of adverse event, Overall survival, Relapse free survival | — |
Countries
Japan
Contacts
Public ContactHironobu Suto
Faculty of Medicine, Kagawa University Gastroenterological Surgery
Outcome results
None listed